AUS
NZ
UK
CA
USA
IND
Healthcare
CSL (ASX:CSL): Is This Healthcare Giant Still a Staple in ASX200?
May 02, 2025 12:55 PM AEST| By Team Kalkine MediaHighlights,CSL revenue grows at 12.8% CAGR over three years,Profit reaches $2.64 billion in FY24,Debt/equity ratio,remains,balanced at 62.8%,Shares of biotechnology heavyweight,CSL (ASX:CSL),have seen a decline of 10.69% since the start of 2025, spar...
Nyrada (ASX:NYR) Advances Clinical Trials with NYR-BI03 Amid ASX 200 Biopharma Developments
May 02, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,Nyrada (ASX:NYR) progresses to a new phase in its clinical evaluation of NYR-BI03,NYR-BI03 demonstrates effectiveness in neuroprotection and cardiac research models,Collaborative studies expand the therapeutic profile of NYR-BI03 in brain...
Race Oncology Reaches Critical Trial Milestone with RC220 Cancer Drug
May 02, 2025 11:10 AM AEST| By Team Kalkine MediaHighlights,First patient dosed in Phase 1 RC220 trial,Breakthrough formulation,eliminates,prior safety concern,Global trial expansion planned in 2025,Race Oncology (ASX:RAC) has marked a significant milestone with the successful dosing of the first p...
Healius (ASX:HLS) Surges on ASX 200 After $822 Million Imaging Unit Sale
May 01, 2025 06:29 PM AEST| By Team Kalkine MediaHighlights,Healius rallies post Lumus Imaging divestment,$822 million cash proceeds boost company momentum,Special dividend announced as part of reshaping strategy,Healius (ASX:HLS), a prominent player in Australia's healthcare sector, saw its shares...
ASX Health Sector Update: ILA, TYP, DXB, OIL Drive Innovations on All Ordinaries
May 01, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights:,Island Pharmaceuticals completed Phase 2a/b dengue trial and advanced Galidesivir acquisition,Tryptamine Therapeutics progressed psilocin-based TRP-8803 in binge eating disorder trial,Dimerix secured DMX-200 licensing deals and advanced P...
Imugene Ramps Up Clinical Momentum Amid Strong Trial Results and ASX 200 Positioning
May 01, 2025 03:55 PM AEST| By Team Kalkine MediaHighlights,Imugene reports strong trial outcomes for azer-cel in DLBCL,Fast Track Designation granted by US FDA for azer-cel therapy,Expanded patents and improved cash reserves boost growth potential,Imugene Ltd (ASX:IMU) advanced significantly in th...
Dimerix Secures Major US Partnership for Kidney Drug Amid Growing ASX 200 Healthcare Momentum
May 01, 2025 02:29 PM AEST| By Team Kalkine MediaHighlights,Dimerix inks US licensing deal with Amicus for kidney drug DMX-200,Agreement includes up to US$560 million in milestone payments,Addresses urgent need for treatment in rare kidney disease FSGS,Australian biotech company Dimerix (ASX:DXB) h...
EVE Health Makes Bold Therapeutics Pivot with Nextract Deal, Tapping Into Multi-Billion-Dollar Markets | ASX 200 Watch
May 01, 2025 02:16 PM AEST| By Team Kalkine MediaHighlights,EVE Health pivots into global therapeutics with Nextract acquisition,Targets erectile dysfunction and period pain markets,Launch plans underway with expansion into MENA region,EVE Health (ASX:EVE) is embarking on a transformative journey,...
ASX 200 Short Interest Review: BHP, Sigma Pharmaceuticals, and Alcoa Movement Overview
April 30, 2025 10:15 PM AEST| By Team Kalkine MediaHighlights:,Short interest trends observed across,BHP Group,(ASX:BHP), Sigma Pharmaceuticals (ASX:SIP), and Alcoa Corporation (ASX:AAI),Shifts recorded in overall short positioning across selected stocks in the materials and healthcare sectors,Weekly...
Is Sonic Healthcare (ASX:SHL) Undervalued in 2025? A Closer Look at the Metrics
April 30, 2025 05:10 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare shares trade below historical valuation levels,Revenue shows marginal growth, while profit has declined,Debt levels are notable but equity position remains stronger,The share price of Sonic Healthcare (ASX:SHL), one of the...
Can Pro Medicus (ASX:PME) Bounce Back? A Closer Look at the Radiology Software Leader
April 30, 2025 04:30 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus' core tech supports entire radiology process,Visage platform enables remote, real-time diagnostics,Strong fundamentals despite recent share price dip,After a strong multi-year run, shares of,Pro Medicus Ltd (ASX:PME),have dippe...
Zelira Therapeutics Enhances Capital Strength and Advances Clinical Pipeline
April 29, 2025 05:59 PM AEST| By Team Kalkine MediaHighlights,Zelira secures over $1 million through R&D tax refund,Establishes new equity funding avenue via ATM facility,Completes debt-to-equity conversion, enhancing balance sheet,Zelira Therapeutics (ASX:ZLD) has taken several strategic steps to en...
4DMedical (ASX:4DX) Delivers Strong Revenue Growth and Strategic Advances in FY2025
April 29, 2025 05:27 PM AEST| By Team Kalkine MediaHighlights,4DMedical revenue surges 103% year-to-date,Strategic U.S. and Australian partnerships strengthen growth,Regulatory milestones advance global market expansion,4DMedical (ASX:4DX) has reported an impressive 103% increase in operating revenue...
InteliCare (ASX:ICR) Expands AI Reach with mecwacare Collaboration at Trescowthick Centre
April 29, 2025 05:15 PM AEST| By Team Kalkine MediaHighlights,InteliCare (ICR) partners with mecwacare for AI platform trial.,$212,000 initial agreement signed for deployment at Trescowthick Centre.,Potential expansion across mecwacare’s facilities based on trial success.,InteliCare Holdings Ltd (ASX...
Paradigm Biopharmaceuticals (ASX:PAR) Sets the Stage for Next Growth Chapter with Phase 3 Trial Launch
April 29, 2025 05:11 PM AEST| By Team Kalkine MediaHighlights,Paradigm Biopharmaceuticals launches Phase 3 trial for knee osteoarthritis treatment,Strong financial position with $24.56 million cash balance reported,Shareholder loyalty initiatives introduce potential for over $110 million in future ca...
CSL and Pro Medicus: Two ASX Healthcare Giants Gaining Attention in 2025
April 29, 2025 02:26 PM AEST| By Team Kalkine MediaHighlights,CSL (CSL) shows resilience with growing dividends despite share price pullback.,Pro Medicus (PME) gains strong momentum, soaring from 52-week lows.,Healthcare sector innovations drive long-term investor interest.,The Australian healthcare...
Algorae Pharmaceuticals Boosts Drug Pipeline and AI Capabilities with AlgoraeOS 2.0
April 29, 2025 01:33 PM AEST| By Team Kalkine MediaHighlights,AlgoraeOS identifies 24 new drug targets in major oncology areas,AI-116 shows potential dementia treatment superiority,Strong cash position supports expanding R&D efforts,Algorae Pharmaceuticals (ASX:1AI) is making strong strides in drug d...
Sudden Exit: Telix Pharmaceuticals Board Member Anne Whitaker Steps Down
April 29, 2025 10:43 AM AEST| By Team Kalkine MediaHighlights,Anne Whitaker steps down from,Telix,board after a short tenure.,Resignation,driven,by personal and family circumstances.,Telix,Pharmaceuticals expresses support for Whitaker’s future endeavors.,Telix Pharmaceuticals (ASX:TLX) has announced...
ResMed Delivers Solid Performance Amidst Ongoing Market Leadership
April 28, 2025 09:31 PM AEST| By Team Kalkine MediaHighlights:,ResMed's third-quarter fiscal result showed steady growth despite typical seasonal challenges and currency fluctuations.,The company continues to expand its presence in the global obstructive sleep apnea market through innovative smart de...
ASX Healthcare Leader: ResMed’s Steady Growth in the OSA Market
April 28, 2025 08:53 PM AEST| By Team Kalkine MediaHighlights:,ResMed remains a dominant player in the global obstructive sleep apnea market, alongside Philips, with a strong presence in over 140 countries.,Third-quarter fiscal results showed positive growth despite typical seasonal challenges, with...
Advertise your brand on Kalkine Media